cataract co management oct 03 2010
DESCRIPTION
Cataract Co-management from the Optometric Perspective by Dr. Fernando AuzaTRANSCRIPT
Cataract Co-management from the Optometric perspective
R. Fernando Auza, O.D.
Visionary Ophthalmology
Bethesda, MD
OD/MD Cataract Co-Management
Why? Expansion of patient variety and opportunity for practice growth Educational process that expands your knowledge Opportunity to become an expert With development of Multifocal/Toric IOL’s, Cataract Surgery has
evolved into “Refractive Cataract Surgery” Potential for added revenue through premium IOL co-
management 50+ market is expected to grow seven times faster than any
other segment OD’s play an integral role in selecting and recommending IOL
Before referring your patient to a Cataract surgeon
Discontinue Contact Lens wear two to three weeks in advance so that axial length and keratometry measurements are accurate for precise IOL calculation. RGP’s Soft lenses with low dK/t Patients on Extended Wear Contac Lenses
Careful evaluation of Ocular Surface
Management of surface disease will improve final visual outcome
Tear dysfunction syndrome
Lid margin disease
Evaluation of Ocular Surface
Map-dot-fingerprint dystrophy
Post Op – Day 1
History – Problem focused Exam
VA – Usually should be 20/40 or better Anterior Segment Exam
Corneal Surface/Stroma Anterior chamber inflammation Lens centration and PCO
IOP Plan – Medications – Antimicrobial/Anti-inflamatory
therapy Zymar or Vigamox/Xibron/Prednisolone 1% t.i.d.
Follow up visit – three weeks/sooner PRN
Potential complications one day after surgery
IOP Spike Bollous Keratopathy Decentered/Dislocated/Rotated Toric IOL Tilted Lens Peaked pupil – vitreous prolapse Retained lens fragments RD
Post-Op Visit Two – Two to three weeks after surgery
Problem focused history Exam
VA Anterior segment
Ocular Surface/Cornea Anterior changer Lens centration – crucial with multifocal IOL Axis location – must dilate toric IOL’s
IOP – Inflammation/Steroid Responders Refraction Medications – Discontinue antimicrobials. Tapper off steroids and
NSAID if A/C quite. Continue steroid/NSAID therapy if necessary Follow up visit – one month
Complications at week at second post-op visit
Poor visual outcome – must investigate
Previous pathology? Front to back approach
Ocular Surface- (not a post-operative complication)
Dry eye MGD EBMD
Corneal Edema/Bollous Keratopathy
Endothelial dysfunction Persistent A/C reaction
Treat with steroids and Muro 128 ung or sol.
Keep IOP low
Severe Iritis - Must Investigate
May just take longer to resolve in some patients History of previous iritis/autoinmune disease Irido-Lenticular contact if IOL tilted
Can affect VA May have to reposition IOL
IOL outside capsular bag inferiorly
Persistent Iritis - Continued
Retained Lens Fragments If iritis is persistent – must perform carefull DFE
looking for small fragments Fragments may be within the capsular bag
Posterior Capsular Opacity Treat early PCO greatly affects VA and contrast sensitivity
specially with multifocal IOL’s Decentered/Dislocated
Surgeon will have to reposition IOL
Cystoid Macular Edema
More common in diabetics
Sub-Clinical CME may be difficult to detect without OCT or Fluorescein angiography
Post Operative Epiretinal Membrane
Incidence - 22% - only 3.6% visually significant Visually insignificant ERM also known as
Cellophane Macular Reflex Visually Significant ERM – Maculr Pucker
Post-Operative Endophthalmitis
Incidence 0.1% Patient present with pain, photophobia,
floaters, reduced vision, an inflamed anterior segment including a variable hypopyon, and vitritis
May present four to seven days after surgery